BIOTRONIK Neuro today announced the launch of Embrace One® Proactive Intelligence, a proprietary AI capability that advances ...
Soin Neuroscience, a Dayton, Ohio-based medical device innovator founded by pain management physician Amol Soin, M.D., today ...
Medical device company Biotronik Neuro has acquired a portfolio of intellectual property related to spinal cord stimulation from Soin Neuroscience. The patents include technologies in spinal cord ...
Medical Device Network on MSN
BIOTRONIK Neuro acquires Soin Neuroscience’s SCS IP portfolio
The acquisition follows a previous research collaboration between Soin Neuroscience and BIOTRONIK Neuro in December 2025.
Biotronik Neuro has acquired a portfolio of spinal cord stimulation patents from the Ohio-based medical device company Soin Neuroscience as the pair look to create “a next-generation spinal cord ...
Soin Neuroscience announced today that it sold intellectual property related to spinal cord stimulation (SCS) to Biotronik Neuro.
A local company has sold a portion of its Dayton-made medical treatment portfolio to a multi-billion-dollar firm. The ...
A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal muscle atrophy (SMA), an inherited neuromuscular disease. An intervention, ...
Please provide your email address to receive an email when new articles are posted on . Spinal cord stimulation offers relief for patients who have not responded to other treatments for chronic ...
Boosting communication between the spinal nerves and the muscles using the spinal cord stimulation reverses spinal muscle atrophy (SMA) progression and could be applied to other motoneuron diseases, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results